(en) Jürgen Koscielny, Christoph Rosenthal et Christian von Heymann, « Update on Direct Oral AntiCoagulants (DOACs) », Hamostaseologie, vol. 37, no 4, , p. 267–75. (ISSN2567-5761, PMID29582929, DOI10.5482/HAMO-16-10-0041)
(en) Turpie AGG, Bauer KA, Davidson BL, Expert Study Group et al., « A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) », Thromb Haemost, vol. 101, no 1, , p. 68-76. (PMID19132191, DOI10.1160/TH08-07-0460)
(en) Connolly SJ, Eikelboom J, Dorian P et al., « Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) », Eur Heart J, vol. 34, no 20, , p. 1498-505. (PMID23487517, PMCIDPMC3659305, DOI10.1093/eurheartj/eht039, lire en ligne [html])
(en) Alexander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber et Russell D. Hull, « Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients », N Engl J Med, vol. 375, no 6, 08 11, 2016, p. 534–44. (ISSN1533-4406, PMID27232649, DOI10.1056/NEJMoa1601747)
(en) Jürgen Koscielny, Christoph Rosenthal et Christian von Heymann, « Update on Direct Oral AntiCoagulants (DOACs) », Hamostaseologie, vol. 37, no 4, , p. 267–75. (ISSN2567-5761, PMID29582929, DOI10.5482/HAMO-16-10-0041)
(en) Alexander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber et Russell D. Hull, « Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients », N Engl J Med, vol. 375, no 6, 08 11, 2016, p. 534–44. (ISSN1533-4406, PMID27232649, DOI10.1056/NEJMoa1601747)
(en) Jürgen Koscielny, Christoph Rosenthal et Christian von Heymann, « Update on Direct Oral AntiCoagulants (DOACs) », Hamostaseologie, vol. 37, no 4, , p. 267–75. (ISSN2567-5761, PMID29582929, DOI10.5482/HAMO-16-10-0041)
(en) Turpie AGG, Bauer KA, Davidson BL, Expert Study Group et al., « A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) », Thromb Haemost, vol. 101, no 1, , p. 68-76. (PMID19132191, DOI10.1160/TH08-07-0460)
(en) Connolly SJ, Eikelboom J, Dorian P et al., « Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) », Eur Heart J, vol. 34, no 20, , p. 1498-505. (PMID23487517, PMCIDPMC3659305, DOI10.1093/eurheartj/eht039, lire en ligne [html])
(en) Alexander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber et Russell D. Hull, « Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients », N Engl J Med, vol. 375, no 6, 08 11, 2016, p. 534–44. (ISSN1533-4406, PMID27232649, DOI10.1056/NEJMoa1601747)
(en) Connolly SJ, Eikelboom J, Dorian P et al., « Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) », Eur Heart J, vol. 34, no 20, , p. 1498-505. (PMID23487517, PMCIDPMC3659305, DOI10.1093/eurheartj/eht039, lire en ligne [html])